PerkinElmer Q4 Revenues Up 10 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its revenues climbed almost 10 percent in the fourth quarter.

For the three months ended Jan. 2, the firm said revenues totaled $470 million, compared to $428.5 million for the year-ago period. It exceeded consensus Wall Street estimates of $461.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.